The 21st Century Cures Act impacts all healthcare stakeholders, but many are unsure what it requires of them. Will the Cures Act upend my business model? What is information blocking? What must I do now as well in the next five years?
Aligning your organization with the Cures Act mandates will require collaboration and interoperability among providers, EHR vendors, health information exchanges, and the industry at large.
To help healthcare leaders understand both the challenges and the opportunities that the Cures Act presents, we assembled a panel of leading healthcare experts across the health IT spectrum to share their unique perspectives and experiences addressing the mandate. Panelists will offer practical and direct guidance on how you can prepare for the Cures Act.
This presentation is for healthcare leaders including CIOs, Hospital IT Directors, HIE Directors/Managers, EMR IT Managers, Physicians, Compliance Managers, and other healthcare technology executives or end-users that are interested in learning about the Cures Act, and the business practices industry leaders are using to meet the requirements and make a difference within their organizations.
Attendees of this webinar will be able to:
1) Gain insight to how the Cures Act affects health IT interoperability.
2) Discuss how Cures Act rules impact health IT business models.
3) Identify how standardized technologies can be applied to meet Cures Act requirements.
4) Take away practical perspectives on how the industry can prepare for the Cures Act.
Panelists:
William E. Golden, MD MACP – Medical Director, Arkansas Medicaid
Anne Santifer – Executive Director, Office of Health Information Technology for the State of Arkansas
Kyle Meadors – Principal, Chart Lux Consulting
Video Rating: / 5
The National Organization for Rare Disorders (NORDⓇ), Critical Path Institute (C-Path), and the US Food and Drug Administration (FDA) present a special webinar on the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), a collaborative project with C-Path, NORD, and the FDA. RDCA-DAP is an integrated database and analytics hub that is designed to be used in building novel tools to accelerate drug development across rare diseases.
This webinar explores why your organization should contribute to the RDCA-DAP, how to submit data to the platform, and how you can access and use the data and analytics platform. NORD, C-Path, and FDA will be available to answer specific questions about the project.
Video Rating: / 5
